Salix Coronary Plaque vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Artrya
VS
by M3DICINE

AI Verdict

Tool A, Salix Coronary Plaque, specializes in AI-driven analysis of CCTA scans for detailed assessment of coronary artery plaque and stenosis, making it suitable for diagnosing coronary artery disease. In contrast, Tool B, Stethee Pro 1, is an AI-enabled digital stethoscope system focused on real-time cardiac and respiratory vital sign analysis from auscultation, ideal for initial assessments, monitoring, and telemedicine. While both contribute to cardiology, they address different diagnostic modalities and stages of patient care.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your primary need is a detailed, AI-driven analysis of CCTA scans to precisely quantify coronary artery plaque and stenosis. This tool is ideal for cardiologists and radiologists seeking to identify high-risk plaque features and enhance the accuracy of coronary artery disease diagnosis and risk stratification from imaging data.

View Salix Coronary Plaque →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require a portable, AI-enabled digital stethoscope for real-time cardiac and respiratory vital sign analysis at the point of care or in telemedicine settings. This system is best suited for clinicians needing immediate auscultation insights, advanced sound amplification, and secure data sharing for rapid diagnostic assessment in various clinical environments.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Salix Coronary Plaque Stethee Pro 1
Pricing Subscription model $499 usd
Deployment Cloud-based (Amazon Web Services), web-based software application Cloud, Mobile
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Stethee Pro 1

Stethee Pro 1, with its wireless digital stethoscope and mobile application, offers a more immediate and versatile user experience for a wider range of clinical settings and telemedicine. Its ability to capture vital signs in 20 seconds suggests high ease of use for quick assessments. Salix Coronary Plaque, while streamlining CCTA analysis, is tied to a more complex imaging workflow requiring specialist interpretation.

Clinical Value

Salix Coronary Plaque

Salix Coronary Plaque provides a definitive and detailed diagnostic assessment of coronary artery disease by analyzing complex CCTA imaging data, including the identification of high-risk plaque features. This has a profound impact on patient management and preventative care for a critical condition. Stethee Pro 1 enhances physical examination and provides real-time vital sign analysis, which is valuable for screening and monitoring, but less definitive for complex disease diagnosis.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 offers transparent upfront device pricing at $499 and a clear subscription model for its web portal, facilitating easier budgeting and cost predictability. Salix Coronary Plaque's 'contact for pricing' and per-scan assessment model, while potentially reimbursable at US$950 per assessment, lacks initial transparency regarding overall cost of ownership.

Enterprise Readiness

Stethee Pro 1

Stethee Pro 1 explicitly states HIPAA compliance and 'likely' a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. Its deployment across mobile and cloud platforms with secure data sharing also makes it versatile for various enterprise settings, including telemedicine. While Salix Coronary Plaque is cloud-deployed and FDA-cleared, the explicit HIPAA/BAA claims give Stethee Pro 1 an edge in demonstrating enterprise readiness.

Innovation

Salix Coronary Plaque

Salix Coronary Plaque's AI-driven CCTA analysis for precise, near real-time characterization of coronary plaque and stenosis, including high-risk features, represents a significant advancement in non-invasive diagnostic imaging for a critical disease. Stethee Pro 1 innovates by transforming a traditional stethoscope into a smart, connected, AI-powered diagnostic and monitoring tool, but Salix's innovation addresses a more complex, high-stakes diagnostic problem.

Support & Docs

Stethee Pro 1

Stethee Pro 1 provides a more comprehensive and readily accessible suite of user-focused documentation, including detailed 'Getting Started' guides, 'How-to' articles for hardware and software, and a mobile app tutorial. While Salix Coronary Plaque mentions a user guide, Stethee Pro 1's publicly available resources appear more extensive for self-help and device operation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Salix Coronary Plaque Stethee Pro 1
Product Name Salix Coronary Plaque Stethee Pro 1
Company Artrya Limited M3DICINE Pty Ltd.
Primary Function AI-driven software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans. AI-enabled wireless digital stethoscope system for real-time cardiac and respiratory vital sign analysis.
Target Medical Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Pulmonology
Core Input/Technology CCTA scans Wireless digital stethoscope system capturing cardiac and respiratory vital signs.

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Salix Coronary Plaque is designed for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that provides real-time cardiac and respiratory vital sign analysis from auscultation, enhancing diagnostics and telemedicine.
Salix Coronary Plaque operates on a per-scan assessment model, with a US CPT reimbursement rate of US$950 per assessment. Stethee Pro 1 has an upfront cost of $499 for the device, plus a required subscription for its Stethee Central web portal to access advanced AI-driven analytics and insights.
Salix Coronary Plaque primarily targets Cardiology and Radiology specialties. Stethee Pro 1 is designed for use across Cardiology, Emergency Medicine, and Pulmonology.
Salix Coronary Plaque provides AI-enabled CCTA analysis for detection and quantification of coronary plaque, identification of high-risk plaque features, stenosis assessment, and calcium scoring. Stethee Pro 1 offers AI-enabled real-time analysis of cardiac and respiratory vital signs, including measures of systole, diastole, heart cycle durations, and respiration rate, along with visualization of heart and lung sounds.
Salix Coronary Plaque offers automated report generation that is editable and provides near real-time, point-of-care assessment. Stethee Pro 1 includes sophisticated sound amplification, proprietary digital filters, automatic geo-location, and environmental data tagging (humidity, temperature, pollen count, pollution).
AI Tool Finder
AI-powered search. Results may not be comprehensive.